Copy of Newspaper Publication

GLAND PHARMA LIMITED GLAND September 29, 2026 BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, 5th floor 25th floor, Dalal Street Plot no. C-1, Block G, Bandra Kurla Complex Bandra Mumbai - 400 001 (East), Mumbai - 400 051 Scrip Code: 543245 Symbol: GLAND (ISIN: INE068V01023) Dear Sir/Madam, Sub: Newspaper Publication - Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed copies of the newspaper publication titled “Notice for attention of members of Gland Pharma Limited” published in the English and Telugu newspapers. This is for your information and records. Yours truly, For Gland Pharma Limited Sampath Kumar Pallerlamudi Company Secretary & Compliance Officer Encl: As above Regd. Office: Corporate Office: Survey No. 143-148, 150 & 151, Near Gandimaisamma ‘X’ Roads Plot No. 11 & 84, TSIIC Phase: IV D.P. Pally, Dundigal, Dundigal-Gandimaisamma Mandal Pashamylaram (V), Patancheru (M), Sangareddy District Medcha l-Malkajgiri District, Hyderabad 500043,Telangana, India Hyderabad 502307, Telangana, India Tel: +91-40-30510999 Fax: +91-40-30510800 Tel: +91-8455-699999 CIN: L24239TG1978PLC002276 | email: gland@glandpharma.com; investors@glandpharma.com | www.glandpharma.com Continuation Sheet Business Standard – September 29, 2026 HYDERABAD | TUESDAY, 29 SEPTEMBER 2026 BOCSS Wlllll :::::: : :r; ; r=:; : ■: : M i GLAND PHARMA LIMITED Cwpmpta ldanflftcah<wi Nuirtoer (CIN) - L!4239TGl9?flPl-C0022?ii CLANI R»g t«r*d Offca Sy No. 143- 148. 150 and 151, Near Gandnuraun'Tia X Roadi. DP. Pally. Ound HJ. OufKfa l |Mj, Msdcftnl-Ma- jflin Dhtrid. Hyderabad 5QQ IH3, TdHrtflrtha Indin Tel: 91-44)-3051<1999: E-mail invBEliXE qandphanna.Gam: Webart*: ww# a ardpharma corn NOTICE FOR ATTENTION OF MEMBERS OF GLAND PHARMA LIMITED In order to send the notices of General Meetings and / or Postal Ballot, Annual Report and other statutory communication to the shareholders in electronic form, we request the shareholders of the Company who have not yet registered / updated their e-mail address, to register/update the e-mail in the manner as mentioned below: a) Members holding shares in physical mode and who have not registered/ updated their e-mail address with the Company are requested to register/ update with MUFG Intime India Private Limited (formerly known as Link intime India Private Limited), Company's Registrar and Transfer Agent, by sending an e-mail at rnLhelDdesk@in.mnrns.mufo cbm or by sending an e-mail to the Company at inyestors@qIandphaTma.com along with Folio No. and valid e-mail address. b) Members holding shares in Dematerialised mode are requested to register/ update their e-mail address with the Depository Participant with whom the demat accounts) is maintained. For Gland Pharma Limited Sd/- Place : Hyderabad Sampath Kumar Pallerlamudl Dale ; September 28, 2026 Company Secretary & Compliance Officer GLAND Continuation Sheet Andhra Prabha- September 29, 2026 &0W0 29-9-2026 5 GLAND PHARMA LIMITED CorpctW IMMotlto Ntxnb* |C*M1 - L2423flTc3-i9 ?SPiCttJ2t?« ■CLAN R Mn OMM. Sy. No tai41 iSDwvd Ul, N«r OiTdnwiunml X? R«d>. D P Prfy, CHxxj|»*. Ounctytf -GwriknAtawnmi <iMi Owfcl, Hydembrt 300 tMJ, IW an* trd* TW S1-40-3M1UW8: E-mail 'Matefe www sMpfUm* ®m rroS OisSJS 2*<5&) £j£d>£ >6cdLu f EJc e giStS’t J*O> £i3&C d&iiis;. eSAitw ScOoixf »£f<5 Si j't3*cr ;rtrcj*do <j ig©<T icj oto a £>ejjrr\ «-2 wd Odof3*£j*cu autfid&r Sj"c5j iS<£jj£ / «-£icl45 £o1}eb J'£j' ,O'dL?t5£. £Kj3 "LC' fStJ Jt ■Q- jcoj<j Sj*do Tb Eirr / ttSilt? CScdb v rr 3*££jtfc&-r3 dj. -0} cirori 3g©c5* failA jCiodja m3 s-Bo-scotff O-dbmij*vc i5i_xl> > ?iCogw 3<j- ioOoix- w 3jswj«5" rnvestors@glandphaiTna.com ig -Socoj« cr-cr <Jcr mt. helpdesk@m mpms.mufg.com ig s»- Z oLo ;iw3&£i Cr cr MIJFG 5£5a goilcO 3dS i/ZX>Ci-t, (so££o ©oS J3& , CJjStS ©£>3E3firr cxj iu36) £o" £>o 0£ £> oOduOu 3J*C1> Zi So£’ ’5iwA.o&m / wSdiT S*<5wcJj m dj, £r) iSc SacdjtSg' £gSeS* mtrvo <fak cx> m& Aij* (cw) rid &*QtJBa3 w’jELsa gTs"tnje5o* mD Odbmiiu* cSSj'ij- ois ofiofirfT’ / 4 Sj o?bo&rr For Gland Pharma Unified Sdr- Place : Hyderabad Sampath Kumar Pallertemudl Date . September 23, 2026 Company Sscnefary A CompJrance Officer